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BP180/collagen XVII is a hemidesmosomal trans-
membrane molecule serving as cell-surface receptor.
Mutations in its gene cause junctional epidermolysis
bullosa. Here, we report a patient with mutations in
the gene for BP180/collagen XVII, COL17A1, but
predominant phenotypic features of epidermolysis
bullosa simplex. At birth, the proband presented
with bullous lesions on the trunk, face, and hands.
Ultrastructurally, hemidesmosomes were fairly nor-
mal, but the attachment of intermediate ®laments
with the hemidesmosomal plaques appeared to be
impaired. Blister formation demonstrated both intra-
epidermal and junctional cleavage. Immuno¯uores-
cence staining with antibodies to keratins, several
hemidesmosomal proteins, and the extracellular
domain of BP180/collagen XVII showed normal
staining patterns, whereas an antibody against the
intracellular domain of BP180/collagen XVII yielded
a negative immuno¯uorescence signal. Analysis of
BP180/collagen XVII cDNA revealed a 1172 bp dele-
tion corresponding to an in-frame deletion from Ile-
18 to Asn-407 from the intracellular domain of the
polypeptide. Mutation analysis of the COL17A1 gene
disclosed a paternal nonsense mutation, R1226X, and
a large maternal genomic deletion extending from
intron 2 to intron 15, but no mutations in basal kera-
tin genes. These ®ndings underline the functional
importance of the intracellular BP180/collagen XVII
domain for the interaction of hemidesmosomes
with keratin intermediate ®laments and for the
spatial stability of basal keratinocytes, and provide a
functional explanation for the epidermolysis-bullosa-
simplex-like phenotype. Further, the data demon-
strate that defects in a given gene can cause
unexpected phenotypes of epidermolysis bullosa
categories, depending on the function of the affected
protein domain. Key words: bullous pemphigoid/geno-
dermatoses/mutation. J Invest Dermatol 118:185±192, 2002
T
he name epidermolysis bullosa (EB) refers to the
mechanically induced detachment of the epidermis
from the dermis, into the blister roof. Based on
ultrastructural criteria, EB is divided into three main
categories according to the precise level of blister
formation: simplex, junctional, and dystrophic subtypes (Fine et al,
2000). In EB simplex (EBS), a disease caused by keratin or plectin
mutations (Corden and McLean, 1996; Uitto et al, 1996), the tissue
separation takes place within the basal keratinocytes, whereas in
junctional EB (JEB) the cleavage occurs along the lamina lucida of
the basement membrane zone. JEB is a heterogeneous group of
autosomal recessive bullous disorders (Darling et al, 1997;
Pulkkinen and Uitto, 1998). The patients are clinically character-
ized by life-long blistering of skin and mucous membranes, diffuse
alopecia, partial absence of eyelashes, eyebrows, pubic and axillary
hair, nail dystrophy, and dental anomalies (Hashimoto et al, 1976;
Hintner and Wolff, 1982; Fine et al, 2000). At the ultrastructural
level, cleavage occurs in the lamina lucida or at the lamina lucida/
basal cell interface. Hemidesmosomes and the associated anchoring
®laments are rudimentary or absent. Immuno¯uorescence staining
of EB skin with antibodies to the structural components of the
basement membrane zone is the key diagnostic tool used to
determine the EB category (Fine et al, 2000). In JEB, the staining
shows hemidesmosome components in the blister roof and lamina
densa components in the blister base. In addition, immuno¯uores-
cence studies reveal abnormal expression of BP180/collagen XVII
(Jonkman et al, 1995; McGrath et al, 1995; Pohla-Gubo et al, 1995)
or of laminin 5 (Jonkman et al, 1995) in JEB skin.
BP180/collagen XVII, initially identi®ed as a major target of IgG
autoantibodies in bullous pemphigoid patients, is a transmembrane
glycoprotein with a type II orientation, i.e., the amino-terminal
domain localizes to the cytoplasm and the extracellular carboxy-
terminal end spans the lamina lucida of the basal membrane zone
(Li et al, 1993; Masunaga et al, 1997). It is a structural component of
hemidesmosomes in strati®ed and other complex epithelia, such as
skin, mucous membranes, and the eyes. Recent cell transfection
and yeast-two hybrid experiments have demonstrated that the
intracellular domain of BP180/collagen XVII interacts with b4
integrin and BP230, and the juxtamembranous extracellular
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domain with a6 integrin. These interactions are important in the
formation and stabilization of the hemidesmosomes (Hopkinson
et al, 1995; Borradori et al, 1997; Hopkinson and Jones, 2000).
Recently, a number of mutations in the COL17A1 gene,
encoding BP180/collagen XVII, have been described (Pulkkinen
and Uitto, 1998; 1999). The majority of them are premature
termination codons resulting in accelerated mRNA decay, but in
some cases missense mutations have been found (McGrath et al,
1996; Schumann et al, 1997; Floeth et al, 1998). A small number of
patients with a nonlethal JEB phenotype show mutations in the
genes coding for laminin 5 (Jonkman et al, 1996; Pulkkinen et al,
1998) with normal BP180/collagen XVII expression. Finally, a
family with bigenic inheritance, with mutations in both the
COL17A1 and LAMB3 genes, was recently identi®ed (Floeth and
Bruckner-Tuderman, 1999).
Here we report a striking case presenting with characteristic
phenotypic features of mainly EBS. At the molecular level, the
phenotype was caused by compound heterozygous mutations in the
COL17A1 gene. The paternal mutation caused a premature stop
codon at position 1226, and the maternal mutation was a large
genomic deletion extending from intron 2 through intron 15. This
leads to in-frame skipping of exons 3±15, a gene segment that
encodes for a large portion of the cytoplasmatic domain of BP180/
collagen XVII.
MATERIALS AND METHODS
Clinical case The male proband of this study was born at the thirty-
ninth week of gestation after an uneventful pregnancy. He was the
offspring of noncosanguinous healthy parents and had two older maternal
half-brothers who were clinically unaffected. At birth, he was noted to
have disseminated isolated and grouped blisters on the scalp, face, hands,
feet, buttocks and scrotum, nail beds and buccal mucosa (Fig 1A). No
other abnormalities or developmental defects were noted. With
advancing age, blisters tended to occur on physically stressed skin of the
face, hands, and feet, and healed initially without scarring (Fig 1B). At
the age of 5 mo milia were noted on the left heel. Currently, this 3-y-
old patient shows disseminated blistering and mild atrophic scarring on
knees and elbows, as well as bilateral thickening of big and second toe
nails. Otherwise, the patient shows normal skin, adnexal, and mucosal
structures, i.e., no signs of alopecia, loss of eyelashes, enamel defects, or
caries. Informed consent was obtained from the parents prior to further
investigations. Human in vivo studies were approved by the local research
ethics review committee.
Electron microscopy Electron microscopic examination of a skin
biopsy from clinically unaffected skin was performed using standard
methods (Frenk et al, 1996). In short, 1 mm3 nonlesional skin samples
were ®xed in 2.5% glutaraldehyde, post®xed in osmium tetraoxide, and
embedded in Epon. Ultrathin sections were stained in uranyl acetate and
lead citrate and observed using a Phillips CM10 electron microscope.
Cell culture Punch biopsies obtained from the patient and normal
volunteers were used to establish primary keratinocytes on lethally
irradiated murine 3T3 ®broblasts in keratinocyte complete medium
(Dulbecco's modi®ed Eagle's medium/Ham's F12 3:1, 10% fetal bovine
serum, hydrocortisone 0.4 mg per ml, choleratoxin 0.1 nM, insulin 5 mg
per ml, adenine 20 mg per ml, apotransferrin 5 mg per ml,
triiodothyronine 2 nM, epidermal growth factor 10 ng per ml, penicillin
100 U per ml, and streptomycin 0.1 mg per ml) (Rheinwald and Green,
1975; 1977; Green et al, 1979). Keratinocytes at passages 2±6 were used
for the experiments. Cell extracts used for immunoblot analysis were
isolated from keratinocytes cultured in serum-free keratinocyte growth
medium (Sigma, Buchs, Switzerland) containing 50 mg of ascorbic acid
per ml for 48 h before harvest.
Isolation of RNA and northern blot analysis Total RNA was
isolated using the guanidine-thiocyanate method (Chomczynski and
Sacchi, 1987). Denaturing of RNA gels using 13 mg of total RNA per
lane and transfer to Zetaprobe membrane (Bio-Rad, Hercules, CA) were
carried out as described earlier (Huber et al, 1997). Membranes were
hybridized with 32P-labeled 5¢ (residues 97±636) and 3¢ (residues 3665±
4402) probes of the BP180/collagen XVII cDNA (GenBank M91669).
Final washes were performed in 30 mM NaCl, 3 mM sodium citrate, and
0.1% sodium dodecyl sulfate, pH 7, at 65°C for 30 min.
Southern blot analysis Genomic DNA was digested with XhoI
(Roche Biochemicals, Rotkreuz, Switzerland) according to the recom-
mendations of the supplier. The digested DNA was electrophoresed and
transfered to Zetaprobe membrane (Bio-Rad, Switzerland). Membranes
were probed with a 32P-labeled fragment of exon 2 of the COL17A gene
(nucleotides 103955±104205; GenBank AL138761). After overnight
incubation at 65°C, the membrane was washed in 30 mM NaCl, 3 mM
sodium citrate, and 0.1% sodium dodecyl sulfate, pH 7, at 65°C for
30 min and then exposed for 7 d to XAR-5 autoradiographic ®lm.
Cloning of cDNA by reverse transcription polymerase chain
reaction (RT-PCR) To analyze cDNA fragments from the patient
and unaffected individuals, total RNA from cultured keratinocytes was
used for RT-PCR using the Advantage cDNA PCR kit (Clontech, Palo
Alto, CA) with the primers BP7 (5¢-ATTCCTTCAAAACCTCAA-
ACC-3¢; nucleotides 72±92 of BP180/collagen XVII cDNA M91669)
and BP8 (5¢-GCTCCTCCTGGCTGTCACTGT-3¢; nucleotides 1116±
1095 of BP180/collagen XVII cDNA M91669). Reaction conditions
were as follows: 94°C for 2 min, and then 35 cycles at 94°C for 30 s,
55°C for 30 s, and 68°C for 3 min. Ampli®ed fragments were cloned
into the pGEM-Teasy vector (Promega, Madison, WI) and subjected to
sequence analysis.
Protein concentrations Protein content was determined with the
Bradford assay (Bio-Rad) using bovine serum albumin as standard
(Bradford, 1976).
Mutation detection Genomic DNA was isolated from peripheral
blood using the QIAamp blood kit (Qiagen, Basel, Switzerland). PCR
ampli®cation of all COL17A1 (GenBank U76564±U76604) exons was
carried out as described previously (Gatalica et al, 1997). Ampli®cation of
COL17A1 exon 51 was performed using the following primers: sense
Figure 1. Clinical features of the patient. (A) Presence of grouped
blisters on the buttock at birth. (B) Patient at the age of 7 mo showing
blisters at different stages after trauma, which were healing without
scarring.
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primer 5¢-TTTCTCTCCTCCCATCACCC-3¢ and antisense primer 5¢-
TGTCCCTTTAAGTGCCTCCC-3¢. The size of the PCR product was
374 bp. Heteroduplex analysis was performed according to Ganguly et al
(1993), and heteroduplex-forming PCR products were sequenced with
an automated sequencer (Genome Express, Grenoble, France).
The deletion was de®ned using PCR ampli®cation of COL17A1
exons 2±16 directly from genomic DNA. The primers used were sense
primer 5¢-TTATCAGCTTCAACAGTGGG-3¢ and antisense primer 5¢-
CATCATCTGGTCCATTAGCC-3¢. The PCR ampli®cation of normal
control DNA showed a number of large products, but the ampli®cation
of the patient's DNA generated a distinct band of about 1500 bp, which
was further characterized by southern blotting. The hybridization was
performed with a BP180/collagen XVII cDNA fragment spanning exons
14±17, which was labeled with digoxigenin (Digoxigenin DNA Labeling
Kit, Roche, Mannheim, Germany). The detection was performed with
alkaline-phosphatase-labeled digoxigenin antibodies and CDP-Star sub-
strate.
The dideoxynucleotide sequencing of the 1500 bp fragment was
performed with nested PCR and automated sequencing in both direc-
tions. For detection of the entire sequence, additional intronic primers
were used for ampli®cation: sense primer 5¢-TTATGTGTCAAA-
GAATCCCAAAGGTC-3¢ (designated TH2up) and antisense primer 5¢-
TTGTTCCTGAGTCCGTGATGC-3¢ (TH16do). The sequence was
veri®ed by digesting the fragment with EcoRI/PvuII and cloning into
the EcoRI/EcoRV sites of the pBIISK+ vector (Stratagene, La Jolla,
CA), followed by automated sequencing. For sequencing of intron 2 in
normal controls, the sense primer was TH2up and the antisense primer
was 5¢-GGAAGGGTGCTCCTGGTAAGTC-3¢ (NK3do). For sequenc-
ing of intron 15 in normal controls, the sense primer was 5¢-
AACCACATTTCTTGACGATGCC-3¢ (NK15up) and the antisense
primer was TH16do.
PCR ampli®cation and sequence analysis of keratin genes K5 and K14
were carried out as described previously (Shemanko et al, 2000).
Antibodies and immunodetection of proteins Antigen mapping
(Hintner et al, 1981) was performed using the following antibodies for
immuno¯uorescence staining of 5 mm cryosections of the patient's and
control skin: cytokeratins (Dako, Hamburg, Germany), BP230 (a high
titer autoantiserum), a BP180/collagen XVII antibody raised against the
recombinant NC16a domain (Schumann et al, 2000), BP180/collagen
XVII antibodies 1A8c and 1D1 (kind gift of Dr. K. Owaribe, Nagoya
University, Nagoya), a6 and b4 integrins (Gibco Life Technologies,
Eggenstein, Germany), collagen IV (Dako), laminin 5 (kind gift from Dr.
R. Burgeson, CBRC, Harvard Medical School, Cambridge, MA), and
collagen VII (Bruckner-Tuderman et al, 1995).
For immunoblotting, keratinocytes were extracted with a buffer
containing 0.1 M NaCl, 20 mM Tris±HCl, pH 7.4, 1% Nonidet P-40,
and proteinase inhibitors (Schumann et al, 1997; SchaÈcke et al, 1998),
and the proteins were separated on a 4.5±15% sodium dodecyl sulfate
polyacrylamide gel. Proteins in the culture medium were precipitated
with chloroform/methanol and subjected to immunoblotting in a similar
manner. As antibodies, polyclonal antibodies against a recombinant
fragment (ecto-1) spanning about 200 of the most carboxy-terminal
amino acids of BP180/collagen XVII, the NC16a antibody against the
recombinant NC16a domain, and the antibody Ab-Col15-2 against the
recombinant Col15 domain (SchaÈcke et al, 1998; Schumann et al, 2000;
Tasanen et al, 2000) were used.
RESULTS
Immuno¯uorescence analysis reveals absence of BP180/
collagen XVII intracellular domain The patient's clinical
symptoms at birth were compatible with EB. This was re¯ected by
histology showing that during blister formation epidermal±dermal
tissue separation could occur either at the level of the lamina lucida
of the basement membrane or within the basal keratinocytes
(Fig 2). Further investigation with antigen mapping of the patient's
skin demonstrated that staining patterns for keratins K5 and K14,
a6b4 integrin, BP230, collagen IV, plectin, and laminin 5 were
normal. In contrast, the signals with antibodies against BP180/
collagen XVII were unanticipated. Monoclonal antibody 1A8c
against the intracellular domain exhibited no staining at all, but
antibodies against the extracellular domain showed normal signals
in most regions of the epidermal basement membrane zone (Fig 2).
These ®ndings were suggestive of aberrant expression of BP180/
collagen XVII in the patient's skin. As the EBS-like features were
prominent, cultured keratinocytes derived from the patient's skin
were stained with antibodies against keratins K5 and K14. No ball-
like aggregates typical for cultured EBS cells were found in the
proband's keratinocytes, however, suggesting that keratin
intermediate ®laments were formed normally (data not shown).
Keratin intermediate ®laments are abnormally attached to
hemidesmosomes Electron microscopic examination of the
proband's dermo-epidermal junction revealed hemidesmosomes of
varying width and structure. Within the basal keratinocytes, the
keratin intermediate ®lament bundles did not appear to properly
attach to the hemidesmosomal cytoplasmic inner plaque. The other
morphologic structures of the basement membrane zone, i.e., the
lamina lucida, lamina densa, and the anchoring ®brils, appeared
normal (Fig 3).
No full-length BP180/collagen XVII mRNA or protein is
found in cultured keratinocytes from the patient Northern
blot analysis of total RNA obtained from cultured normal
keratinocytes demonstrated a 6 kb mRNA band with BP180/
collagen XVII cDNA probes from the 5¢ and 3¢ end (Fig 4). In
contrast, when total RNA from the patient's keratinocytes was
Figure 2. Immuno¯uorescence staining for
the intracellular domain of BP180/collagen
XVII is absent in the patient's skin. Frozen
sections from control and patient skin were
incubated with antibodies against the intracellular
and extracellular BP180/collagen XVII domains.
(A) Staining of normal control skin with
antibodies to the extracellular NC16a domain of
BP180/collagen XVII. (B) Strongly reduced
staining of the patient's skin with the NC16a
domain antibodies in one skin biopsy. The faint
staining is localized in the roof of a small blister
(the star denotes the blister cavity), indicating
junctional blister formation. (C) Positive staining
of the patient's skin with the NC16a antibodies in
a second skin biopsy. In this specimen, the signal
is observed on the ¯oor of the blister, indicating
intraepidermal splitting. (D) Staining of control
skin with antibody 1A8c against the intracellular
domain of BP180/collagen XVII. (E) Negative
staining of patient's skin with antibody 1A8c. (F)
Positive staining of patient's skin with antibody
1D1 against the extracellular domain of BP180/
collagen XVII.
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hybridized with a 5¢ end probe that spans the intracellular domain
of the protein, no signal was found. As a 3¢ probe revealed a
diminished size of BP180/collagen XVII mRNA, the ®ndings
were suggestive for an internal deletion within the 5¢ segment
(Fig 4).
Immunoblot analysis of keratinocyte extracts and media was
performed to visualize a putative truncated polypeptide corres-
ponding to the short mRNA observed with northern blotting.
Antibodies recognizing the extracellular domain BP180/collagen
XVII revealed two bands in extracts of normal keratinocytes, with
molecular weights of 180 and 120 kDa (Fig 5). The 180 kDa band
corresponds to the full-length transmembrane molecule, and the
120 kDa band to the soluble, shed ectodomain (SchaÈcke et al,
1998). In culture medium, only the 120 kDa ectodomain was
present. Analysis of the patient's keratinocytes showed the presence
of the 120 kDa band in the medium and cell extracts, whereas the
180 kDa transmembrane form was absent. Instead, the cell extract
contained a polypeptide of approximately 130 kDa (Fig 5). This
truncated polypeptide was recognized by antibodies to the NC16a
domain and to the distal C-terminus of the molecule, indicating
that the entire ectodomain was present. In contrast, antibodies to
the intracellular domain did not recognize it. Thus, the protein
results were in agreement with the mRNA analysis and implicated
a mutation that produced an in-frame deletion in the 5¢ end of the
mRNA and yielded a BP180/collagen XVII polypeptide chain that
was shortened by about 50 kDa in its intracellular domain.
Nevertheless, the truncated molecule was anchored to the cell
plasma membrane and shed in an apparently normal manner.
Mutational analysis demonstrates a large genomic deletion
from intron 3 to intron 15 due to a 42 bp sequence
homology The initial search for mutations in the keratin genes
K5 and K14 did not reveal any sequence abnormalities. RT-PCR
analysis of the patient's keratinocyte RNA using the BP180/
collagen XVII primers BP7 and BP8 (see Materials and Methods)
revealed a 500 bp band, compared with a 1600 bp band obtained
with control RNA (data not shown). Cloning and sequencing of
the 500 bp band revealed a large deletion in the cDNA extending
from nucleotide position 158 to 1329, which corresponded
precisely to the omission of exons 3 through 15. This translates
to an in-frame deletion in the polypeptide from Ile-18 to Asn-407,
thus encompassing a major part of the intracellular domain of the
BP180/collagen XVII polypeptide.
Heteroduplex analysis of genomic DNA of the patient provided
evidence for two different genetic aberrations in the COL17A1
gene. Dideoxynucleotide sequencing revealed a heterozygous C-
to-T transition at position 3781 leading to the premature termin-
ation codon R1226X (Fig 6B). The mutation eliminated the
consensus sequence for TaqI restriction enzyme, and veri®cation by
TaqI digestion showed that it was paternally inherited (Fig 6A, B).
PCR analysis with primers placed in exons 2 and 16 generated a
1500 bp amplimer with the patient's and his mother's DNA, but
not with DNA from the father or from normal controls. This
Figure 3. Electron microscopy reveals
abnormalities in hemidesmosome and
keratin intermediate ®lament structures.
Heterogeneous hemidesmosomes of varying size
and structure were found in the proband's skin.
Moreover, the keratin intermediate ®lament
bundles do not extend into the hemidesmosomes.
The other ultrastructural units of the basement
membrane zone, lamina lucida, lamina densa, and
the anchoring ®brils appeared normal. Bar:
0.25 mm.
Figure 4. Northern blot analysis shows a large deletion in the 5¢
part of the BP180/collagen XVII mRNA. Total RNA was isolated
from keratinocytes cultured in high calcium medium established from
the patient (lanes 1, 4) and from normal control individuals (lanes 2, 3, 5,
6). The northern blot was hybridized with a BP180/collagen XVII 5¢
probe (nucleotides 97±636, GenBank M91669) in lanes 1±3, or with a
BP180/collagen XVII 3¢ probe (nucleotides 3555±4402, GenBank
M91669) in lanes 4±6. As loading control glyceraldehyde-3-phosphate-
dehydrogenase was used to ensure equal amounts of RNA.
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suggested a maternally inherited deletion that reached from intron 2
to intron 15. Subsequent sequence analysis of normal controls
disclosed an identical 42 nucleotide stretch in both introns 2 and
15. In the proband's DNA, only one 42 bp stretch was present and
it was ¯anked at the 5¢ end by a normal intron 2 sequence and at
the 3¢ end by a normal intron 15 sequence (Fig 6C). Searching the
COL17A sequence (GenBank AL138761) with the 42 bp sequence
shows indeed that introns 2 and 15 contain this sequence
(nucleotides 103161±103203 and 82167±82209); in both cases
this sequence is part of the highly conserved AluSg repeats.
Southern blot analysis using XhoI-digested DNA and a BP180/
collagen XVII exon 2 probe revealed, as predicted by the COL17A
sequence (GenBank AL138761), a 27 kbp fragment in normal
DNA and two bands at 27 and 6 kbp in patient DNA (Fig 7). This
argues that an Alu-mediated mutational event had occurred that
removed the 21 kbp stretch of DNA between the two 42 bp
repeats. The deletion was not found in either 150 normal
chromosomes or 28 chromosomes of other unrelated EB patients,
indicating that it does not represent a neutral polymorphism.
Taken together, the mutation analysis, combined with RNA and
protein assays, showed that the patient was hemizygous for the
deletion. Like many mutations leading to premature termination
codons, R1226X led to nonsense-mediated mRNA degradation, as
both northern blots and immunoblots failed to demonstrate the
presence of full-length BP180/collagen XVII mRNA or polypep-
tide chains.
DISCUSSION
BP180/collagen XVII, a type II transmembrane protein, presum-
ably functions as a cell-adhesion receptor providing a connection
between extracellular matrix ligands and the intracellular keratino-
cyte intermediate ®lament network. Support for this role emerged
from its abnormal expression caused by mutations in the COL17A1
gene in JEB patients (Pulkkinen and Uitto, 1999). Absence of
BP180/collagen XVII as a consequence of null mutations leads to
severe epidermal dysadhesion, whereas missense mutations causing
structural abnormalities in the extracellular domain lead to
unfolding of the triple helix, susceptibility to proteolytic degrad-
ation, and functional insuf®ciency (Tasanen et al, 2000).
In this study, we investigated an EB patient with phenotypic
features of mainly EBS. This analysis provides genetic evidence for
the function of BP180/collagen XVII as linker molecule between
the keratin intermediate ®lament network and the extracellular
matrix proteins at the dermal±epidermal junction. Whereas the
expression of several hemidesmosomal proteins and their ligands,
e.g., a6b4 integrin, BP230, collagen IV, plectin, laminin 5, and
keratins K5 and K14, was normal, the expression of BP180/
collagen XVII was aberrant. The absence of the intracellular
domain of BP180/collagen XVII was evident by immuno¯uores-
cence, immunoblot, and northern blot analysis, whereas the
extracellular segment of the polypeptide was present normally in
the patient's skin. Genetic analysis revealed compound hetero-
zygosity of the proband for two different aberrations in the
COL17A1 gene. The paternal defect R1226X is a recurrent
mutation that has been described in both homozygous and
heterozygous forms (Jonkman et al, 1997; Schumann et al, 1997;
Floeth et al, 1998; Floeth and Bruckner-Tuderman, 1999). The
premature termination codon presumably leads to nonsense-
mediated mRNA decay (Schumann et al, 1997; Floeth et al,
1998; Floeth and Bruckner-Tuderman, 1999) as northern blots
showed no evidence for the expression of normal size mRNA. The
proband's cells contained a 130 kDa truncated polypeptide;
however, it was not clear whether the shortened length resulted
from a deletion or, potentially, from a C-terminal truncation caused
by the premature termination codon. Immunoblotting with a panel
of domain-speci®c BP180/collagen XVII antibodies identi®ed only
one kind of truncated chain, which spanned the entire ectodomain
but lacked a segment from the intracellular domain, thus excluding
the possibility of a C-terminally truncated BP180/collagen XVII
polypeptide.
Thus, the proband was functionally homozygous (hemizygous)
for the maternal mutation. This resulted in skipping of exons 3±15
and elimination of amino acids 18±407 from the BP180/collagen
XVII polypeptide, generating an intracellular domain that consisted
of only 76 amino acids instead of the normal 466 residues. This
®nding was consistent with the negative immuno¯uorescence and
immunoblot ®ndings obtained with monoclonal antibody 1A8c,
the epitope of which has been mapped to the region between the
amino acids 113±201 of BP180/collagen XVII (Borradori et al,
1997). The truncated molecule is stable, and both mRNA and
protein expression levels seemed to be equivalent to those in
normal individuals.
The 21 kbp genomic deletion extends from intron 2 to intron
15. Both introns contain the same perfectly matched 42 nucleotide
long region (5¢-aactcctgacctcgtgatctgcccgcctcggcctcccaaagt-3¢),
which is part of a larger (approximately 300 bp) repeat homologous
to the Sg member of the Alu repeat family (GenBank AL138761).
Sequences similar to these two Alu repeats are not found elsewhere
in the COL17A1 gene. Both Alu repeats have the same orientation
and display a sequence similarity of 84%, which is even higher
around the 42 bp region of homology. Introns 2 and 15 contain in
addition to the Alu repeats other interspersed repetitive elements
such as (GT)n (TGTA)n, MER41B, and MER5A repeats.
Therefore, it seems likely that the genomic deletion is due to a
recombination event that occurred between the two AluSg repeats
using the 42 bp stretch as crossover point. Alu-mediated genomic
rearrangements have been shown to be involved in other inherited
diseases such as Fanconi anemia (Morgan et al, 1999), familial
hypercholesterolemia (Lehrman et al, 1987), hereditary angiedema
(Stoppa-Lyonnet et al, 1990), and pseudoxanthoma elasticum
(Ringpfeil et al, 2001), as well as in genetic predisposition for
colon and breast cancer (NystroÈm-Lahti et al, 1995; Puget et al,
1999). Moreover, tandem duplication mediated by Alu-dependent
recombination in somatic tissue has been reported in cases of acute
myeloid leukemia (Strout et al, 1998). It is likely that secondary
structures formed by the regions of homology and components of
Figure 5. Immunoblot analysis reveals that patient keratinocytes
produce only BP180/collagen XVII of 130 kDa molecular weight.
Proteins extracted from cultured cells and culture medium were
immunoblotted with the NC16a antibody. Lane 1: Both full-length
BP180/collagen XVII (upper arrowhead) and the shed ectodomain (lower
arrowhead) were present in cell extracts from normal keratinocytes (Co).
Lane 2: The shed ectodomain was precipitated from the medium of
normal keratinocytes. Lane 3: The cell extracts of the patient's
keratinocytes (EB) contained mutant BP180/collagen XVII polypeptide
of approximately 130 kDa (arrow) and the shed ectodomain (lower
arrowhead). Lane 4: The soluble ectodomain was present in the medium
of the patient's keratinocytes (lower arrowhead). Identical results were
obtained when using antibodies against the carboxy-terminal region or
against the Col15 domain (see Materials and Methods). On the right, the
migration positions of molecular weight standards, from top to bottom
200 kDa, 111 kDa, 80 kDa, and 46 kDa, are shown.
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the DNA replication and recombination machinery may play a role
in the generation and subsequent deletion of loop structures.
Recent cell biologic studies provide explanations for the biologic
and clinical phenotype of the present proband. They have shown
that the intracellular domain of BP180/collagen XVII contains
sequences important for the localization of the protein into
hemidesmosomes and its interaction with other hemidesmosomal
components, such as the intracellular domain of the b4 integrin
subunit and the N-terminal region of BP230 (Hopkinson et al,
1995; Borradori et al, 1997; Aho and Uitto, 1998; Schaapveld et al,
1998; Hopkinson and Jones, 2000). There is strong evidence that
an N-terminal 401 amino acid stretch of BP180/collagen XVII
contains binding sites to the N-terminal region of BP230 and the
C-terminal half of the cytoplasmic domain of b4 integrin (Geerts
et al, 1999; Koster et al, 1999; Hopkinson and Jones, 2000). In
addition, the cytoplasmic domain of BP180/collagen XVII may
also associate with plectin (Aho and Uitto, 1997). Therefore, the
deletion of the region Ile18±Asn407 is expected to impair the
association of BP180/collagen XVII not only with b4 integrin and
BP230 but also with plectin.
Both plectin and BP230 are cytoplasmic components of
hemidesmosomes that are believed to attach the keratin cyto-
skeleton to the hemidesmosomal plaque and, by means of
interactions with the cytoplasmic domains of BP180/collagen
XVII and b4 integrin, to the plasma membrane (Guo et al, 1995;
Uitto et al, 1996; Andra et al, 1997; Borradori and Sonnenberg,
1999). Therefore, it is likely that the poor linkage of intermediate
®laments to hemidesmosomes observed by electron microscopy in
the proband's skin results from an impaired incorporation and/or
stabilization of BP230 and plectin into hemidesmosomes as a result
of perturbed interactions with the cytoplasmic domain of BP180/
collagen XVII. Moreover, the reduced attachment of keratin
®laments to the basal plasma membrane might account for the
increased mechanical fragility of keratinocytes, thus explaining the
blistering arising in the basal layer and the clinical EBS-like
phenotype.
The extracellular domain of BP180/collagen XVII appeared to
be expressed normally as shown by immunoblot analysis. In
concert, antibodies to the extracellular domain of BP180/collagen
XVII showed linear immuno¯uorescence staining along the
basement membrane zone of the patient's skin, a staining pattern
indistinguishable from normal controls. Nevertheless, as also
junctional cleavage was seen in the proband's skin, dermo-
epidermal cohesion must be impaired as well. It is likely that the
Figure 6. Pedigree and mutation analysis in
the COL17A1 gene. (A) The pedigree of the
family demonstrates that the mutation R1226X
(black areas) and the genomic deletion (dotted areas)
of the proband (1) occurred in a compound
heterozygous manner, because the father (3) is the
carrier of R1226X and the mother (2) of the
deletion. (B) Sequence analysis of the patient's
PCR product containing exon 51 showed a C-to-
T transition at nucleotide position 3781,
designated R1226X. A restriction endonuclease
site for Taq1 is eliminated by the mutation.
Accordingly, the 342 bp PCR product (upper
band) of a normal control (C1) and the mother (2)
were cleaved into a 185 bp (lower band) and a 157
bp fragment, whereas the proband (1), the father
(3), and a previously characterized unrelated
patient with the same mutation (C2) showed an
additional uncleaved band of 342 bp. (C) The
maternal mutation was a large genomic deletion,
extending from intron 2 to intron 15. In normal
controls, an identical 42 bp sequence was found
within both introns. In the proband's DNA, this
42 bp sequence is present once and is ¯anked at
the 5¢ end by the sequence corresponding to
normal intron 2 (underlined) and at the 3¢ end by
the sequence corresponding to normal intron 15
(doubly underlined).
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large deletion of the cytoplasmic domain BP180 not only
compromises molecular associations important for the stabilization,
and thus function, of hemidesmosomes, but also has an impact on
the interaction of the extracellular domain of BP180/collagen XVII
with extracellular matrix protein(s).
The genetic, biochemical, and clinical data obtained here extend
the spectrum of the phenotypic heterogeneity of EB. They
demonstrate for the ®rst time that defects in a given gene can
give rise to clinical and biologic phenotypes characteristic of
different EB categories, depending on the function of the protein
domain affected by the mutation. This work also underlines the
importance of using intracellular-domain-speci®c BP180/collagen
XVII antibodies for assessment by antigen mapping of EB patients
to avoid faulty diagnosis.
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